Drug-Related Growth Studies
Collaborations with the FDA.
The U.S. Food and Drug Administration has post-market evidence of immunosensitivity caused by four popular drugs. They've contracted Pure to see what parts of the drugs’ structure are presented by the cell’s HLA protein when the cell is grown in the presence of these drugs. This is a continuing body of research that Pure has been performed for the FDA using Pure sHLAs.